John Marcinak
4PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 18, 2018
Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.John F Marcinak, Melvin S Munsaka, Paul B Watkins
|Mar 02, 2018
Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.John F Marcinak, Melvin S Munsaka, Paul B Watkins
|Mar 01, 2018
Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment.John Marcinak, Majid Vakilynejad, Akifumi Kogame
|Feb 28, 2017
Combining the G-protein-coupled receptor 40 agonist fasiglifam with sitagliptin improves glycaemic control in patients with type 2 diabetes with or without metformin: A randomized, 12-week trial.Xuejun V Peng, John F Marcinak, Marsha G Raanan
Pageof 1
